Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Major Shareholding Notification 2019

Oct 8, 2019

4017_mrq_2019-10-08_25774802-8d36-44ed-9d85-657ebc3d1085.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

Transparency notification BlackRock, Inc.

Notification referring to situation on 2 October 2019

Threshold crossed: 5%Latest holding: 5.18%

Brussels (Belgium), 8 October 2019 – 20:00 (CEST) – regulated information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.), dated 3 October 2019.

BlackRock, Inc., has notified that, following a disposal of UCB shares with voting rights by its affiliates, its holding of UCB shares with voting rights has decreased and has crossed downwards the 5% threshold on 2 October 2019.

On 2 October 2019, BlackRock, Inc. (taking into account the holding of its affiliates) Inc. owned 9 604 695 UCB shares with voting rights (versus 9 887 511 shares in its previous notification), representing 4.94% of the total number of shares issued by the company (194 505 658) (versus 5.08% in its previous notification), as well as 465 605 equivalent financial instruments (versus 467 613 in its previous notification) representing 0.24% of the total number of shares issued by the company (same % as in its previous notification).

2. Content of the notification

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights.
  • Notification by: A parent undertaking or a controlling person.
  • Persons subject to the notification requirement:

{1}------------------------------------------------

Name Address (for legal entities)
BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Lenbachplatz 1 1st Floor, Munich, 80333-MN3, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 26, 101 Collins Street, Melbourne, VIC 3000, Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan

Date on which the threshold is crossed: 2 October 2019.

Threshold crossed (in %): 5%

Denominator: 194 505 658.

Notified details:

{2}------------------------------------------------

A) Voting rights Previous notification After the transaction
# of voting rights # of voti ng rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
BlackRock, Inc. 0 0 0.00%
BlackRock (Netherlands) B.V. 17,319 17,319 0.01%
BlackRock (Singapore) Limited 8,748 9,230 0.00%
BlackRock Advisors (UK) Limited 1,657,041 1,433,744 0.74%
BlackRock Advisors, LLC 170,817 174,565 0.09%
BlackRock Asset Management
Canada Limited
189,787 194,296 0.10%
BlackRock Asset Management
Deutschland AG
194,093 191,154 0.10%
BlackRock Asset Management North
Asia Limited
2,543 997 0.00%
BlackRock Financial Management, Inc. 290,921 300,590 0.15%
BlackRock Fund Advisors 2,581,363 2,565,837 1.32%
BlackRock Institutional Trust
Company, National Association
3,215,104 3,229,009 1.66%
BlackRock International Limited 96,476 102,057 0.05%
BlackRock Investment Management (Australia) Limited 120,954 130,589 0.07%
BlackRock Investment Management (UK) Limited 454,590 481,826 0.25%
BlackRock Investment Management, LLC 468,419 458,822 0.24%
BlackRock Japan Co., Ltd. 419,336 314,660 0.16%
Subtotal 9,887,511 9,604,695 4.94%
TOTAL 9,604,695 0 4.94% 0.00%

{3}------------------------------------------------

B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent 27,248 0.01% physical
BlackRock Investment Management (UK) Limited Securities Lent 21,466 0.01% physical
BlackRock Investment Management, LLC Securities Lent 8,574 0.00% physical
BlackRock Japan Co., Ltd. Securities Lent 470 0.00% physical
BlackRock Advisors (UK) Limited Contract for Difference 677 0.00% cash
BlackRock Advisors, LLC Contract for Difference 88,962 0.05% cash
BlackRock Institutional Trust
Company, National Association
Contract for Difference 238,462 0.12% cash
BlackRock Investment Management (UK) Limited Contract for Difference 57,597 0.03% cash
BlackRock Investment Management, LLC Contract for Difference 22,125 0.01% cash
BlackRock Investment Management, LLC Depositary Receipt 24 0.00%
TOTAL 465,605 0.24%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 10,070,300 5.18%

• Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the 'Chain of Control' tab.

• Additional information:

The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going below 5%.

{4}------------------------------------------------

3. Further information

This press release and the detailed transparency notification are available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 7 500 people in approximately 40 countries, the company generated revenue of € 4.6 billion in 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news